On Thursday, May 23, C-Path was joined by Dr. Laurent Servais of the University of Oxford and the University of Liège, for an overview of Actimyo and relevant learnings from use cases across rare disorders spanning different degrees of complexity and readiness. Additionally, patient advocacy group leaders will speak to their experience based on stage of development and the ability of Actimyo to assess individuals with a neuromuscular disorder or non-NMDs (e.g., Duchenne muscular dystrophy, Angelman syndrome, and CTNNB1).
View the webinar recording below:
